Apovax-SVN as a novel vaccine for cancer immunotherapy

Ended Block Grant Awarded

Award ID
R41CA121665
Recipient
Awarding agency
Obligated
$328,300

Award facts

Assistance listing
93.395 Cancer Treatment Research
Completion date
Place of performance
Kentucky, USA

Award details come from USAspending.gov.

Quick answers

Who received award R41CA121665?

R41CA121665 was awarded to Apovax, Inc. by National Institutes of Health (Department of Health and Human Services) on September 6, 2007.

How much is award R41CA121665 worth?

$328,300 has been obligated on R41CA121665.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award